Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases-Reference-Cited by-同舟云学术

Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases

Published:2019-09 Issue:5 Volume:86 Page:335-343
ISSN:0006-3223
Container-title:Biological Psychiatry
language:en
Short-container-title:Biological Psychiatry

Author:

Chang Zheng,Ghirardi Laura,Quinn Patrick D.,Asherson Philip^ORCID,D’Onofrio Brian M.,Larsson Henrik

Funder

Swedish Research Council

National Institute of Mental Health

European Union’ Horizon

National Institute on Drug Abuse

National Institute for Health Research Biomedical Research Centre

National Institute for Health Research

Publisher

Elsevier BV

Subject

Biological Psychiatry

Reference103 articles.

1. Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents;Polanczyk;J Child Psychol Psychiatry,2015

2. Predictors of adolescent outcomes among 4–6-year-old children with attention-deficit/hyperactivity disorder;Lahey;J Abnorm Psychol,2016

3. Annual research review: Optimal outcomes of child and adolescent mental illness;Costello;J Child Psychol Psychiatry,2015

4. ADHD in children and young people: Prevalence, care pathways, and service provision;Sayal;Lancet Psychiatry,2018

5. Twenty-year trends in diagnosed attention-deficit/hyperactivity disorder among us children and adolescents, 1997-2016;Xu;JAMA Network Open,2018

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ADHD Assessment and Treatment Services in a Sample of U.S. Colleges and Universities;Psychiatric Services;2024-09-11

2. Risques du méthylphénidate au long cours;Annales Médico-psychologiques, revue psychiatrique;2024-09

3. Transcranial photobiomodulation for neurodevelopmental disorders: a narrative review;Photochemical & Photobiological Sciences;2024-07-15

4. AACAP Endorses the Inclusion of Methylphenidate in the WHO Model Lists of Essential Medicines;Journal of the American Academy of Child & Adolescent Psychiatry;2024-07

5. The clinical pathway in ADMiRE, Ireland’s first public specialist service for children and adolescents with attention deficit hyperactivity disorder;Irish Journal of Psychological Medicine;2024-06-03